Delirium: prescribing safety โ ๏ธ ๐ง
Educational on-call framework โ not a treatment protocol. New confusion is a clinical syndrome: look for treatable causes and non-drug interventions before reaching for sedation.
Investigate first
- Identify infection, hypoxia, glucose disturbance, pain, retention, constipation, dehydration, medication toxicity and withdrawal.
- Use a validated delirium assessment tool appropriate to the setting; ask family about baseline and acute change.
Non-pharmacological first
- Reorientation, sleep, glasses/hearing aids, mobilisation and consistent staff can reduce distress.
- For danger/distress, attempt verbal de-escalation and identify the particular behaviour being treated.
If considering medication
- haloperidol carries QT and neurological risks and is contraindicated in Parkinson disease and Lewy body dementia.
- Consider total anticholinergic burden (e.g., amitriptyline, cyclizine) and sedatives; involve senior/geriatric/psychiatry support.
- Document indication, intended effect, monitoring and review/stop time; do not use routine chemical restraint.
UK resources: NICE CG103 delirium ยท MHRA haloperidol warning
Editorial draft 4 November 2026; not formally clinically signed off. Use local policy and senior advice.